Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adults Aged 50 Years and Older”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Large-scale testing (Phase 3)Study completedNCT03439657
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Who this might be right for
Herpes Zoster
GlaxoSmithKline 913
Testing effectiveness (Phase 2)Study completedNCT06695130
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980
Large-scale testing (Phase 3)Study completedNCT02045836
What this trial is testing

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Who this might be right for
Herpes ZosterHerpes Zoster Vaccine
GlaxoSmithKline 865
Not applicableStudy completedNCT01244295
What this trial is testing

Study of Interpersonal Therapy and Complicated Grief Treatment in Adults 50 Years and Older

Who this might be right for
Complicated Grief
New York State Psychiatric Institute 151
Testing effectiveness (Phase 2)Study completedNCT01513551
What this trial is testing

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 692
Not applicableEnrolling By InvitationNCT06606678
What this trial is testing

The Role of Regular Physical Activity in Enhancing Metabolic Health, Reducing Inflammation, and Improving Gut Function

Who this might be right for
Intestinal InflammationMetabolic Disease
Poznan University of Physical Education 400
Not applicableUnknownNCT03558438
What this trial is testing

Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function

Who this might be right for
HIV InfectionsFrail Older Adults
Fundacion SEIMC-GESIDA 802
Testing effectiveness (Phase 2)Study completedNCT00978029
What this trial is testing

Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)

Who this might be right for
RhinoconjunctivitisRhinitisConjunctivitis+1 more
ALK-Abelló A/S 203
Not applicableLooking for participantsNCT07475039
What this trial is testing

Project HOPEFUL: A PN-RCT With Implementation Science

Who this might be right for
Older Adults (50-90 Years)Mental HealthDepression and Suicide Ideation+4 more
University of Florida 400
Large-scale testing (Phase 3)Study completedNCT03615482
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 1,200
Early research (Phase 1)Looking for participantsNCT07386730
What this trial is testing

Psychedelics in Healthy Older Adults With Low Well-being

Who this might be right for
Anhedonia in Healthy VolunteersOlder Adults (50-90 Years)
Jennifer Mitchell 80
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Large-scale testing (Phase 3)Study completedNCT03480763
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 652
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Large-scale testing (Phase 3)Ended earlyNCT05993143
What this trial is testing

Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50

Who this might be right for
COVID-19SARS-CoV-2
Insud Pharma 249
Testing effectiveness (Phase 2)Study completedNCT06151288
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 1,015
Not applicableStudy completedNCT04831788
What this trial is testing

Pneumococcal Nasopharyngeal and Oropharyngeal Carriage in Adults

Who this might be right for
Preference, Patient
University of Novi Sad 521
Not applicableNot Yet RecruitingNCT07809113
What this trial is testing

PCV21 Acceptance in Adults ≥50 Years and Caregivers in Panama

Who this might be right for
Pneumococcal Immunization
Endpoints Site Network 600
Testing effectiveness (Phase 2)Study completedNCT05501561
What this trial is testing

Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age

Who this might be right for
Influenza, Human
Seqirus 1,056
Next Page